Polish - Swiss Forum for Health Dialogue

Fostering R&D for innovative new treatments – Bridging the gap between scientists and entrepreneurs.
June 22, 2021, 9:00 - 12:30

Poland is strong in the production of pharmaceuticals and in late-stage clinical trials. Some of its researchers have made promising discoveries, but taking their discoveries to market has proven to be much more difficult. What could Poland do to bridge the gap between academia and the private sector? How can Poland strengthen its research and development (R&D) and startup ecosystem in pharma and life sciences?

In this 11th edition of the Polish-Swiss Forum for Health Dialogue, the Embassy of Switzerland and the Polish-Swiss Chamber of Commerce invite researchers, policy-makers, entrepreneurs and industry experts to discuss what the two countries can learn from each other about how to create an environment conducive to successful R&D and investment in the pharma and life sciences sector.

<
Registration

Speakers

Conference agenda

Registration

8:30 - 9:00

Opening Remarks

9:00-9:30

(RECORDING)

H.E. Mr Jürg Burri, Ambasador of Switzerland to Poland (10′)

Anna Goławska, Undersecretary of State, Ministry of Health  (10′)

Michał Stępień, President of the Polish-Swiss Chamber of Commerce (10′)

Keynote Speeches: What are the success factors for innovation in pharma and life sciences in Poland and Switzerland, respectively?

9:30-10:15

Piotr Arak, Director of the Polish Economic Institute (15′) (RECORDING)

Neil Goldsmith, Director Strategy, BaseLaunch (15′) (RECORDING)

Dr Piotr Dardziński, President of Łukasiewicz Research Network (15′) (RECORDING)

Input I: How does Switzerland manage to connect scientists and entrepreneurs to launch and grow biotech companies?

10:15-10:30

Jordi Montserrat, Co-Founder and Managing Partner of Venturelab (15′) (RECORDING)

Input II: Building Biotechs – Corporate Venture Capital & Founder/Management Perspectives

10:30 - 10:50

(RECORDING)

Bart Dzikowski, Managing Director, Head of Transactions & Legal of Novartis Venture Fund; board member at UZH Life Sciences Fund, Oculis S.A. and Enterprise Therapeutics

Dr Michał Walczak, Co-Founder and Chief Scientific Officer, Captor Therapeutics

 

Input III: Personal observations about Poland’s potential from a Swiss expert’s perspective

10:50-11:05

Dr Liliane Brunner Halbach, Global Pharma and Life Sciences Expert (15′) (RECORDING)

Coffe break

11:05 - 11:30

Panel discussion: How to create an environment conducive to successful R&D in pharma and life sciences

11:30-12:20

(RECORDING)

Irma Veberič, General Manager Roche Poland

Dr Radosław Sierpiński, Head of Poland’s Medical Research Agency

Jan Krzewiński, President of Polpharma Biologics Gdańsk

Prof. Jacek Jemielity, bio-organic chemistry, University of Warsaw

Dr hab. Michał Wszola,  CEO of Polbionica Ltd., surgeon transplantologist

Dr Agnieszka Sznyk, Innowo (moderator)

 

Wrapping Up & Conclusions

12:20-12:30

Dr inż. Agnieszka Sznyk, Innowo (moderator)

Venue

The event will take place in a hybrid form – it will be possible to participate online,
as well as in the traditional way, at the venue of the event.

In both cases, please register in advance. After registering, you will receive links to the broadcast
and information on participation in the stationary form.

Venue: Digital Knowledge Village
Puławska 457, 02-844 Warszawa

Tel. +48 22 322 76 25
swisschamber@swisschamber.pl

 

Partners

Organizatorzy:

Patronat honorowy:

Patronages:

Partners:

Registration

on-line registration is closed,
please contact us by phone +48 22 322 76 25